The public issue closed on December 10 after three days of bidding in a price band of Rs 1,020-1,050. The company has now fixed the issue price at Rs 1,050, the upper end of the price band, as per the company's prospectus.
The initial public offering of Alkem Lab elicited robust investor response, with 44.29 times over-subscription.
The quota reserved for qualified institutional buyers (QIBs) was subscribed 57.19 times, while non-institutional investors category was subscribed a staggering 129.96 times.
Retail portion received 3.17 times subscription.
In its prospectus the company said, initial public offering of 1,28,53,442 equity shares for cash at a price of Rs 1,050 aggregating up to Rs 1,346.6 crore.
The offer price of Rs 1,050 has been determined by our company and selling shareholders, in consultation with the GCBRLMs on the basis of demand from investors for the equity shares through the book building process, it said.
Alkem Laboratories had raised Rs 395 crore from anchor investors.
The firm plans to expand its footprint internationally. It had a portfolio of 705 brands in the domestic market as on September 30.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
)